HSA
OSCR icon

Hussman Strategic Advisors’s Oscar Health OSCR Stock Holding History

Hussman Strategic Advisors’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,000
Closed -$173K – 281
2023
Q3 		$173K Hold
31,000
– – 0.03% 266
2023
Q2 		$250K Buy
+31,000
New +$229K 0.05% 265

Other funds holding OSCR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
F
Formation8 Los Altos, California $67.6M AUM
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
Ancient Art Austin, Texas $459M AUM 52.34% 1-Year Est. Return

Hussman Strategic Advisors's OSCR Position: Q4 2023 in Review

Hussman Strategic Advisors sold out of Oscar Health (OSCR) in Q4 2023, closing a stake of 31,000 shares — an estimated $173K sold.

Hussman Strategic Advisors first reported a position in OSCR in Q2 2023 and held it in 2 quarters. The position peaked at $250K in Q2 2023. 188 funds tracked by Wall St. Rank hold OSCR as of Q4 2023.

  • Hussman Strategic Advisors reported no remaining Oscar Health position as of Q4 2023 after selling out during the quarter.
  • Hussman Strategic Advisors sold 31,000 Oscar Health shares in Q4 2023, an estimated $173K.
  • Hussman Strategic Advisors first reported a position in Oscar Health in Q2 2023 and held it in 2 quarters.
  • Hussman Strategic Advisors's Oscar Health position peaked at $250K in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Oscar Health as of Q4 2023.

Based on Hussman Strategic Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.